← Edelweiss Mutual Fund

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth

Equity Data as of Jun 2026 Comparing May 2026 → Jun 2026
Share: WhatsApp X
Stocks Held
25
Jun 2026
Equity Holdings
₹130.89 Cr
Equity only, excl. debt & cash
Top 5 Weight
31.9%
Moderate
Top 10 Weight
49.5%
Moderate
Changes
26
1 new · 1 exits
Top Sector
Pharmaceuticals & Biotechnology
52.6% of portfolio
📋 What Happened This Month Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan made 1 new addition and exited 1 stock this month. The biggest new buy was Anthem Biosciences Limited (Pharmaceuticals & Biotechnology) at 0.43% weight. Emcure Pharmaceuticals Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 0.32%. Among existing holdings, Laurus Labs Limited saw the biggest increase — now at 3.48% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 10.96%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 52.6%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Apr 2026 May 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 54.1% 54.2% +0.1%
Healthcare Services 16.7% 16.5% -0.2%
May 2026 Jun 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 54.2% 52.6% -1.6%
Healthcare Services 16.5% 16.7% +0.2%
🟢
Biggest New Buy
Anthem Biosciences Limited
0.43% weight · Pharmaceuticals & Biotechnology
🔴
Biggest Exit
Emcure Pharmaceuticals Limited
0.32% was held · Pharmaceuticals & Biotechnology
Biggest Add
Laurus Labs Limited
+0.32% · now 3.48%
Biggest Trim
Sun Pharmaceutical Industries Limited
-0.46% · now 10.96%
🤝 Other funds also bought this month
Anthem Biosciences Limited 22 funds
Anthem Biosciences Limited
SBI Retirement Benefit Fund - Aggressive Plan - Direct Plan - Growth
Edelweiss Large Cap Fund - Direct Plan-Growth option
SBI Retirement Benefit Fund - Aggressive Hybrid Plan - Direct Plan - Growth + more
👋 Other funds also exited
Emcure Pharmaceuticals Limited 3 funds
Emcure Pharmaceuticals Limited
Nippon India ELSS Tax Saver Fund - Direct Plan Growth Plan - Growth Option
Groww Nifty Smallcap250 ETF
Motilal Oswal Nifty 50 Index Fund - Direct plan - Growth

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 Jun 2026
🟢 1 New Entry 🔴 1 Exit ↑ 10 Increased ↓ 14 Decreased
#StockSectorWeight (Jun 2026)
1
Anthem Biosciences Limited
₹80.97 L
Pharmaceuticals & Biotechnology 0.43%
#StockSectorLast Weight (May 2026)
1
Emcure Pharmaceuticals Limited
₹56.82 L
Pharmaceuticals & Biotechnology 0.32%
#StockSectorMay 2026Jun 2026Change
1
Laurus Labs Limited
₹6.58 Cr
Pharmaceuticals & Biotechnology 3.16% 3.48% +0.32%
2
Max Healthcare Institute Limited
₹9.84 Cr
Healthcare Services 4.97% 5.21% +0.24%
3
Aurobindo Pharma Limited
₹5.10 Cr
Pharmaceuticals & Biotechnology 2.47% 2.70% +0.23%
4
IPCA Laboratories Limited
₹2.93 Cr
Pharmaceuticals & Biotechnology 1.41% 1.55% +0.14%
5
Ajanta Pharma Limited
₹1.85 Cr
Pharmaceuticals & Biotechnology 0.85% 0.98% +0.13%
6
Gland Pharma Limited
₹2.28 Cr
Pharmaceuticals & Biotechnology 1.10% 1.21% +0.11%
7
Aster DM Healthcare Limited
₹2.26 Cr
Healthcare Services 1.12% 1.20% +0.08%
8
Fortis Healthcare Limited
₹5.80 Cr
Healthcare Services 3.01% 3.07% +0.06%
9
Biocon Limited
₹3.35 Cr
Pharmaceuticals & Biotechnology 1.71% 1.77% +0.06%
10
Global Health Limited
₹1.31 Cr
Healthcare Services 0.63% 0.69% +0.06%
#StockSectorMay 2026Jun 2026Change
1
Sun Pharmaceutical Industries Limited
₹20.70 Cr
Pharmaceuticals & Biotechnology 11.42% 10.96% -0.46%
2
Cipla Limited
₹9.14 Cr
Pharmaceuticals & Biotechnology 5.24% 4.84% -0.40%
3
Torrent Pharmaceuticals Limited
₹5.79 Cr
Pharmaceuticals & Biotechnology 3.46% 3.07% -0.39%
4
Glenmark Pharmaceuticals Limited
₹3.84 Cr
Pharmaceuticals & Biotechnology 2.34% 2.03% -0.31%
5
Dr. Reddy's Laboratories Limited
₹8.39 Cr
Pharmaceuticals & Biotechnology 4.68% 4.44% -0.24%
6
Mankind Pharma Limited
₹3.24 Cr
Pharmaceuticals & Biotechnology 1.95% 1.72% -0.23%
7
Alkem Laboratories Limited
₹2.88 Cr
Pharmaceuticals & Biotechnology 1.74% 1.52% -0.22%
8
Lupin Limited
₹6.83 Cr
Pharmaceuticals & Biotechnology 3.77% 3.62% -0.15%
9
Divi's Laboratories Limited
₹9.71 Cr
Pharmaceuticals & Biotechnology 5.27% 5.14% -0.13%
10
Apollo Hospitals Enterprise Limited
₹10.79 Cr
Healthcare Services 5.83% 5.71% -0.12%

What Stocks Does This Fund Hold?

25 stocks — Jun 2026

# Stock Sector Cap Weight & Value
1
₹20.70 Cr
Pharmaceuticals & Biotechnology
10.96%
2
₹10.79 Cr
Healthcare Services
5.71%
3
₹9.84 Cr
Healthcare Services
5.21%
4
₹9.71 Cr
Pharmaceuticals & Biotechnology
5.14%
5
₹9.14 Cr
Pharmaceuticals & Biotechnology
4.84%
6
₹8.39 Cr
Pharmaceuticals & Biotechnology
4.44%
7
₹6.83 Cr
Pharmaceuticals & Biotechnology
3.62%
8
₹6.58 Cr
Pharmaceuticals & Biotechnology
3.48%
9
₹5.80 Cr
Healthcare Services
3.07%
10
₹5.79 Cr
Pharmaceuticals & Biotechnology
3.07%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 Edelweiss Mutual Fund — Portfolio & Holdings
See all funds managed by Edelweiss Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.